EMILTATUG LEDADOTIN
UNII PTB6AF3CSV

Substance Identification & Data

This profile provides standardized clinical and technical data for Emiltatug Ledadotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PTB6AF3CSV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2855974-40-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
PTB6AF3CSV
CAS Registry Number
2855974-40-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EMILTATUG LEDADOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12944
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emiltatug Ledadotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMILTATUG LEDADOTIN

Common Names & Synonyms

EMILTATUG LEDADOTIN [INN]
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VTCN1(V-SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1, B7 FAMILY MEMBER H4, B7H4, B7-H4)), HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED AT GLYCOSYLATED ASPARAGINYL RESIDUES TO A DERIVATIVE OF AURISTATIN, WITH A RATIO OF 1 TO 6, VIA A CLEAVABLE LINKER